Tel Aviv University researchers discovered that a common multiple sclerosis treatment may have important applications for epilepsy, including Dravet syndrome, which affects children and has a 20 percent mortality rate.

Taking a cue from science fiction, Israeli researchers have invented mind-controlled nanobots that have the potential to treat 'challenging' brain disorders from epilepsy to depression.